Benchmark Research
Benchmark Research, founded in 1997 in Austin, Texas, provides vaccine research and rapid patient enrollment services for clinical trials. Since 2025 it has operated as a site within the Avacare Clinical Research Network, connecting sponsors, CROs, sites, and patients.
- Company typePrivate
- Founded1997
- HeadquartersAustin, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Benchmark Research does
Benchmark Research is a clinical research organization headquartered in Austin, Texas, founded in 1997 and operating with 101-250 employees. The company specializes in vaccine research and rapid patient enrollment services for clinical trials, positioning itself on speed-to-enrollment within the pharmaceutical research services market. Following a 2025 acquisition by QCare Site Services, Inc., Benchmark Research was integrated into the Avacare Clinical Research Network and no longer operates as a standalone entity; the website and customer materials now route to avacare.com.
The core product offering, as reconstituted through Avacare, is a centralized clinical research network that connects four stakeholder groups: sponsors and contract research organizations (CROs), clinical research sites, and patients. Sponsor/CRO-facing capabilities emphasize centralized network access, research-experienced investigators, and data-driven operations intended to accelerate trial timelines while preserving quality. Site-facing capabilities provide tooling, operational support, and access to trial opportunities to reduce administrative burden on investigator sites. Patient-facing capabilities are delivered through a dedicated trial-finder platform (avacareclinicaltrials.com) that surfaces open studies near participants.
The business model is a clinical research site services model under a multi-sided platform wrapper. Specific pricing, contract structures, fee-per-enrolled-patient economics, or revenue mechanics are not disclosed in the available source material. The firm is privately held, with Mark Lacy identified as Owner, Founder, President, and CEO prior to or at the time of integration. The site's product and customer segmentation logic suggests sponsor/CRO contracting as the primary revenue channel, with sites and patients as upstream and downstream participants in the network rather than direct paying customers.
Benchmark Research firmographics
Firmographics- Name
- Benchmark Research
- Legal name
- Benchmark Research
- Website
- https://benchmarkresearch.net
- Company type
- Private
- Founded year
- 1997
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Short description
- Benchmark Research, founded in 1997 in Austin, Texas, provides vaccine research and rapid patient enrollment services for clinical trials. Since 2025 it has operated as a site within the Avacare Clinical Research Network, connecting sponsors, CROs, sites, and patients.
- Ownership category
- akta.pro rank
Benchmark Research industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where Benchmark Research is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Markets served
Benchmark Research business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Benchmark Research product offering
Product offeringCore offering
Benchmark Research provides vaccine and clinical research services with rapid patient enrollment capabilities. Operating as part of the Avacare Clinical Research Network, the company delivers centralized clinical trial execution by connecting sponsors, CROs, research sites, and patients through research-experienced investigators and data-driven operations.
Product overview
Benchmark Research operates as part of Avacare Clinical Research Network, a unified platform offering interconnected services for clinical trial stakeholders. The network provides centralized infrastructure connecting sponsors and CROs with research-experienced investigators, offering data-driven operations support for trial acceleration without compromising quality. Additional services support clinical research sites with tools and trial opportunities, while a dedicated patient platform enables participation in clinical trials near them.
Differentiator
Problem solved
Functional benefit
Companies that use Benchmark Research
Customer profileSegments3 records
Ideal customer profiles3 records
Benchmark Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Benchmark Research partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Avacare Clinical Research NetworkcoreBenchmark Research has become part of Avacare Clinical Research Network, merging to share a common goal of driving healthcare forward to improve patient lives. The combined entity creates meaningful connections between people seeking new treatments and those providing them, with focus on safety, convenience, quality, and speed in clinical trial operations.
Recent moves2 records
Expansion highlights3 records
Benchmark Research competitors and assessment
Company assessmentDirect peers
- Flourish Research: Flourish is a multi-site clinical research organization operating dedicated research sites with a therapeutic mix including vaccines, internal medicine, and specialty indications. Like Benchmark, Flourish supports sponsors and CROs with site-based trial execution and rapid-enrollment capabilities.
- Elligo Health Research: Elligo runs a decentralized network combining traditional sites with technology-enabled trial access for sponsors, with comparable focus on accelerating enrollment. Both Elligo and Benchmark compete for sponsors seeking site-network partnerships that prioritize enrollment speed and quality.
- Velocity Clinical Research: Velocity operates an integrated network of clinical trial sites across the U.S. with a comparable focus on multi-therapeutic trial execution and rapid enrollment. Like Benchmark, Velocity provides centralized infrastructure for sponsors and CROs and competes for similar vaccine and infectious disease trial placements.
Broad incumbents
- ICON plc: ICON operates a global clinical research site network (including via its PRA Health Sciences acquisition) serving sponsors across all major therapeutic areas. Comparable to Benchmark as a competing site-network option for sponsors running vaccine and Phase I–IV trials.
- Syneos Health: Syneos operates a clinical research site network and full-service CRO offering overlapping capabilities in vaccine and therapeutic trial execution. Comparable to Benchmark as a sponsor-facing alternative for site-based clinical research services.
- IQVIA: IQVIA is the world's largest CRO and a direct connection to Benchmark's new parent — Avacare Clinical Research Network is operated by QCare Site Services, Inc., whose website links directly to IQVIA's careers, privacy, and corporate pages. IQVIA's site-management arm is the closest broad incumbent to Benchmark's site-based clinical trial operations.
- Worldwide Clinical Trials: Worldwide is a mid-sized CRO with site-management services spanning vaccines, oncology, and rare disease — directly comparable to Benchmark's therapeutic focus and mid-tier operational scale.
- Medpace: Medpace is a mid-to-large CRO with significant site-management operations and therapeutic specialization across multiple areas including vaccines and infectious disease. Comparable to Benchmark at the sponsor-CRO interface and competes for similar trial placement opportunities via its site network.
Emerging players
- WCG (WIRB-Copernicus Group): WCG provides central IRB services, site enablement technology, and trial optimization tools used by site networks including organizations like Benchmark. Comparable as an enabling partner that supports the operational infrastructure of clinical research sites rather than directly competing for trial placements.
Others
- Clincierge: Clincierge and similar patient-retention/logistics vendors support site networks and CROs with travel and concierge services for trial participants — comparable to Benchmark as part of the broader site-network operational ecosystem that sponsors and CROs coordinate with.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Benchmark Research social profiles
Digital presenceBenchmark Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Benchmark Research leadership team
Management profileNumber of profiles
Profiles1 record
Benchmark Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Benchmark Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Benchmark Research
What does Benchmark Research do?
Benchmark Research provides vaccine and clinical research services with rapid patient enrollment capabilities. Operating as part of the Avacare Clinical Research Network, the company delivers centralized clinical trial execution by connecting sponsors, CROs, research sites, and patients through research-experienced investigators and data-driven operations.
When was Benchmark Research founded?
Benchmark Research was founded in 1997. It employs 101 to 250 people.
Where is Benchmark Research based?
Benchmark Research is headquartered in Austin, United States, in the North America region.
Who are Benchmark Research's main competitors?
Direct peers on record are Flourish Research, Elligo Health Research and Velocity Clinical Research. Broad incumbents are ICON plc, Syneos Health, IQVIA, Worldwide Clinical Trials and Medpace. WCG (WIRB-Copernicus Group) is listed as an emerging player. Clincierge is listed as an others.
Does Benchmark Research have an API?
No public API is recorded for Benchmark Research.
What industry is Benchmark Research in?
Benchmark Research's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 621511 and its SIC code is 8071.